Fertility rate, total (births per woman) in China was reported at 0.999 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Fertility rate, total (births per woman) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Adolescent fertility rate (births per 1,000 women ages 15-19) in China was reported at 5.227 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Adolescent fertility rate (births per 1,000 women ages 15-19) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Historical dataset showing China fertility rate by year from 1950 to 2025.

Birth rate, crude (per 1,000 people) in China was reported at 6.39 % in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Birth rate, crude - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Historical dataset showing China birth rate by year from 1950 to 2025.

The total fertility rate in China increased by 0.02 children per woman (+1.72 percent) in 2022. In total, the fertility rate amounted to 1.18 children per woman in 2022. This increase was preceded by a declining fertility rate.The total fertility rate is the average number of children that a woman of childbearing age (generally considered 15 to 44 years) can hypothetically expect to have throughout her reproductive years. As fertility rates are estimates (similar to life expectancy), they refer to a hypothetical woman or cohort, and estimates assume that current age-specific fertility trends would remain constant throughout this person's reproductive years.Find more statistics on other topics about China with key insights such as death rate, number of tuberculosis infections , and crude birth rate.

The statistic shows the 20 countries with the lowest fertility rates in 2024. All figures are estimates. In 2024, the fertility rate in Taiwan was estimated to be at 1.11 children per woman, making it the lowest fertility rate worldwide. Fertility rate The fertility rate is the average number of children born per woman of child-bearing age in a country. Usually, a woman aged between 15 and 45 is considered to be in her child-bearing years. The fertility rate of a country provides an insight into its economic state, as well as the level of health and education of its population. Developing countries usually have a higher fertility rate due to lack of access to birth control and contraception, and to women usually foregoing a higher education, or even any education at all, in favor of taking care of housework. Many families in poorer countries also need their children to help provide for the family by starting to work early and/or as caretakers for their parents in old age. In developed countries, fertility rates and birth rates are usually much lower, as birth control is easier to obtain and women often choose a career before becoming a mother. Additionally, if the number of women of child-bearing age declines, so does the fertility rate of a country. As can be seen above, countries like Hong Kong are a good example for women leaving the patriarchal structures and focusing on their own career instead of becoming a mother at a young age, causing a decline of the country’s fertility rate. A look at the fertility rate per woman worldwide by income group also shows that women with a low income tend to have more children than those with a high income. The United States are neither among the countries with the lowest, nor among those with the highest fertility rate, by the way. At 2.08 children per woman, the fertility rate in the US has been continuously slightly below the global average of about 2.4 children per woman over the last decade.

China life expectancy for 2025 is 77.81, a 0.22% increase from 2024.

<ul style='margin-top:20px;'>

<li>China life expectancy for 2024 was <strong>77.64</strong>, a <strong>0.22% increase</strong> from 2023.</li>
<li>China life expectancy for 2023 was <strong>77.47</strong>, a <strong>0.22% increase</strong> from 2022.</li>
<li>China life expectancy for 2022 was <strong>77.30</strong>, a <strong>0.22% increase</strong> from 2021.</li>
</ul>Life expectancy at birth indicates the number of years a newborn infant would live if prevailing patterns of mortality at the time of its birth were to stay the same throughout its life.

In 2022, India overtook China as the world's most populous country and now has almost 1.46 billion people. China now has the second-largest population in the world, still with just over 1.4 billion inhabitants, however, its population went into decline in 2023. Global population As of 2025, the world's population stands at almost 8.2 billion people and is expected to reach around 10.3 billion people in the 2080s, when it will then go into decline. Due to improved healthcare, sanitation, and general living conditions, the global population continues to increase; mortality rates (particularly among infants and children) are decreasing and the median age of the world population has steadily increased for decades. As for the average life expectancy in industrial and developing countries, the gap has narrowed significantly since the mid-20th century. Asia is the most populous continent on Earth; 11 of the 20 largest countries are located there. It leads the ranking of the global population by continent by far, reporting four times as many inhabitants as Africa. The Demographic Transition The population explosion over the past two centuries is part of a phenomenon known as the demographic transition. Simply put, this transition results from a drastic reduction in mortality, which then leads to a reduction in fertility, and increase in life expectancy; this interim period where death rates are low and birth rates are high is where this population explosion occurs, and population growth can remain high as the population ages. In today's most-developed countries, the transition generally began with industrialization in the 1800s, and growth has now stabilized as birth and mortality rates have re-balanced. Across less-developed countries, the stage of this transition varies; for example, China is at a later stage than India, which accounts for the change in which country is more populous - understanding the demographic transition can help understand the reason why China's population is now going into decline. The least-developed region is Sub-Saharan Africa, where fertility rates remain close to pre-industrial levels in some countries. As these countries transition, they will undergo significant rates of population growth

DATASET: Alpha version 2010, 2012, 2015, 2020, 2025, 2030, and 2035 estimates of numbers of live births per grid square, with national totals adjusted to match UN national estimates on numbers of live births (http://esa.un.org/wpp/). REGION: Asia SPATIAL RESOLUTION: 0.000833333 decimal degrees (approx 100m at the equator) PROJECTION: Geographic, WGS84 UNITS: Estimated births per grid square MAPPING APPROACH: Tatem AJ, Campbell J, Guerra-Arias M, de Bernis L, Moran A, Matthews Z, 2014, Mapping for maternal and newborn health: the distributions of women of childbearing age, pregnancies and births, International Journal of Health Geographics, 13:2 FORMAT: Geotiff (zipped using 7-zip (open access tool): www.7-zip.org) FILENAMES: Example - AZE2010adjustedBirths.tif = Azerbaijan (AZE) births count map for 2010 adjusted to match UN national estimates on numbers of live births. DATE OF PRODUCTION: May 2014

According to latest figures, the Chinese population decreased by 1.39 million to around 1.408 billion people in 2024. After decades of rapid growth, China arrived at the turning point of its demographic development in 2022, which was earlier than expected. The annual population decrease is estimated to remain at moderate levels until around 2030 but to accelerate thereafter. Population development in China China had for a long time been the country with the largest population worldwide, but according to UN estimates, it has been overtaken by India in 2023. As the population in India is still growing, the country is very likely to remain being home of the largest population on earth in the near future. Due to several mechanisms put into place by the Chinese government as well as changing circumstances in the working and social environment of the Chinese people, population growth has subsided over the past decades, displaying an annual population growth rate of -0.1 percent in 2024. Nevertheless, compared to the world population in total, China held a share of about 17 percent of the overall global population in 2024. China's aging population In terms of demographic developments, the birth control efforts of the Chinese government had considerable effects on the demographic pyramid in China. Upon closer examination of the age distribution, a clear trend of an aging population becomes visible. In order to curb the negative effects of an aging population, the Chinese government abolished the one-child policy in 2015, which had been in effect since 1979, and introduced a three-child policy in May 2021. However, many Chinese parents nowadays are reluctant to have a second or third child, as is the case in most of the developed countries in the world. The number of births in China varied in the years following the abolishment of the one-child policy, but did not increase considerably. Among the reasons most prominent for parents not having more children are the rising living costs and costs for child care, growing work pressure, a growing trend towards self-realization and individualism, and changing social behaviors.

China death rate for 2025 is 8.17, a 2.15% increase from 2024.

<ul style='margin-top:20px;'>

<li>China death rate for 2024 was <strong>8.00</strong>, a <strong>2.21% increase</strong> from 2023.</li>
<li>China death rate for 2023 was <strong>7.82</strong>, a <strong>1.82% increase</strong> from 2022.</li>
<li>China death rate for 2022 was <strong>7.68</strong>, a <strong>1.87% increase</strong> from 2021.</li>
</ul>Crude death rate indicates the number of deaths occurring during the year, per 1,000 population estimated at midyear. Subtracting the crude death rate from the crude birth rate provides the rate of natural increase, which is equal to the rate of population change in the absence of migration.

Snapshot img

Fertility Supplements Market Size 2025-2029

The fertility supplements market size is forecast to increase by USD 843.8 million at a CAGR of 7.3% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing prevalence of stress and the availability of convenient online purchasing options. Stress, a known contributor to infertility, has become a major health concern for individuals seeking to start a family. As a result, the demand for fertility supplements, believed to improve reproductive health and enhance fertility, has rised. However, this market faces challenges, including the potential risks associated with the use of fertility supplements. Moreover, the availability of these supplements through e-commerce platforms has made them easily accessible, increasing their reach and appeal.
To capitalize on the growing demand and navigate the challenges effectively, businesses should focus on research and development, regulatory compliance, and strategic marketing efforts. By addressing these factors, they can position themselves as trusted providers of fertility supplements, meeting the evolving needs of consumers and driving long-term growth in the market. Companies operating in this market must ensure product safety and transparency to mitigate these risks and build consumer trust. Preimplantation genetic testing is increasingly used to identify chromosomal abnormalities and reduce the risk of multiple gestation pregnancies.

What will be the Size of the Fertility Supplements Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

In the fertilizers market, the focus on sustainable farming systems and precision farming methods is driving innovation. Crop nutrition modeling and soil fertility monitoring are key trends, enabling farmers to optimize fertilizer application timing and minimize environmental impact. Sustainable practices, such as soil carbon sequestration and regenerative agriculture principles, are gaining traction. Efficient irrigation systems and stress response mitigation are essential components of modern farming, reducing water usage and enhancing crop productivity. Fulvic acid composition and humate product formulation are integral to organic fertilizer types, offering quality assurance measures and nutrient deficiency diagnosis. Integrated nutrient management, including microbial inoculant types and nutrient management planning, is crucial for optimal plant growth promotion.

Environmental impact assessment and risk assessment methodology are critical for inorganic fertilizer blends and climate-smart agriculture. Precision farming relies on variable rate technology and yield optimization strategies, ensuring efficient fertilizer application and minimizing nutrient loss. Soil testing methods are essential for assessing soil fertility and optimizing fertilizer inputs. The market is also exploring sequestered nutrient release and plant tissue analysis to enhance crop productivity and improve overall farm profitability. Water conservation strategies, such as drip irrigation and rainwater harvesting, are vital in addressing the challenges of climate change and resource scarcity. Inorganic fertilizer blends are undergoing reformulation to reduce their environmental footprint and improve their sustainability.

Overall, the fertilizers market is evolving to meet the demands of modern agriculture, focusing on efficiency, sustainability, and environmental stewardship. Some supplements may carry side effects or interact with medications, leading to health complications. The market is experiencing significant growth due to the increasing prevalence of infertility, driven by various factors including hormonal imbalances, ovulation disorders, and gynecological conditions such as polycystic ovarian syndrome (PCOS) and endometriosis.

How is this Fertility Supplements Industry segmented?

The fertility supplements industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

End-user

  Women
  Men


Form Factor

  Capsules
  Tablets
  Gummies
  Powders
  Others


Product Type

  Herbal supplements
  Vitamin-based
  Mineral-based
  Amino acids and antioxidants
  Probiotics


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    Spain
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By End-user Insights

The Women segment is estimated to witness significant growth during the forecast period. The fertility supplement market in the region is experiencing significant growth due to the increasing demand for these

Snapshot img

Fertility Services Market Size 2025-2029

The fertility services market size is forecast to increase by USD 9.53 billion, at a CAGR of 7.8% between 2024 and 2029.

The market is experiencing significant growth due to the increasing prevalence of late parenthood and the rising number of cases of prostate cancer, which necessitates the use of assisted reproductive technologies. However, this market faces substantial challenges, including the high complication rate in fertility services. The trend toward delayed childbearing, driven by social and economic factors, is leading to a rise in demand for fertility treatments. Furthermore, the growing incidence of prostate cancer, which often results in infertility, is fueling the need for advanced reproductive solutions. However, the high complication rate associated with fertility services poses a significant challenge to market growth.
Addressing this challenge through improved safety measures, rigorous quality control, and enhanced patient education could help mitigate risks and boost market confidence. Companies in the fertility services sector must focus on innovation, patient-centric care, and regulatory compliance to capitalize on the opportunities presented by this dynamic market and navigate the challenges effectively. These include hormone therapy to stimulate ovulation, intrauterine insemination (IUI) and artificial insemination, and embryo transfer using donor eggs or frozen embryos from previous cycles.

What will be the Size of the Fertility Services Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in reproductive technology and growing demand for various infertility treatments. Fertility specialists offer a range of services, including tubal ligation reversal and vasectomy reversal, to help individuals and couples overcome infertility issues. Fertility clinics employ techniques such as ovulation induction, intrauterine insemination (IUI), and in-vitro fertilization (IVF), which involve the use of hormone therapy, reproductive endocrinology, and ovulation induction. Semen analysis, sperm cryopreservation, and surgical sperm retrieval are essential components of infertility diagnosis and treatment. Advanced techniques like embryo freezing, embryo adoption, and donor eggs are also gaining popularity. Genetic counseling and fertility preservation are crucial services that help individuals and couples make informed decisions about their reproductive health.

Reproductive psychology, hysterosalpingography (HSG), and reproductive immunology are additional areas of focus in the market. Fertility medication, assisted hatching, and follicle-stimulating hormone (FSH) testing are integral to the successful implementation of various infertility treatments. Reproductive surgery, egg retrieval, and testicular biopsy are surgical procedures that can help address underlying fertility issues. The ongoing dynamism in the market is reflected in the continuous unfolding of market activities and evolving patterns. These services are applied across various sectors, including gynecology, urology, and reproductive health, to help individuals and couples overcome infertility and achieve their family-building goals.

How is this Fertility Services Industry segmented?

The fertility services industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Service

  Treatment services
  Testing and storage services
  Others


End-user

  Fertility clinics
  Hospitals
  Surgical centers
  Clinical research institutes


Method

  In-vitro fertilization
  Artificial insemination


Gender

  Female
  Male


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    Norway
    UK


  APAC

    China
    India
    Japan


  Rest of World (ROW)

By Service Insights

The treatment services segment is estimated to witness significant growth during the forecast period. The market is driven by the treatment services segment, which accounts for a significant revenue share due to the high cost of services and the prevalence of conditions like diabetes and obesity that affect reproductive health. Additionally, factors such as the increasing trend of late parenthood and the growing awareness and success of advanced reproductive technologies (ART), including in-vitro fertilization (IVF), intrauterine insemination (IUI), and ovulation induction, contribute to market expansion. ART procedures, such as egg retrieval, embryo freezing, and embryo transfer, have seen remarkable breakthroughs, leading to an incr

While the BRICS countries are grouped together in terms of economic development, demographic progress varies across these five countries. In 2019, India and South Africa were the only BRICS countries with a fertility rate above replacement level (2.1 births per woman). Fertility rates since 2000 show that fertility in China and Russia has either fluctuated or remained fairly steady, as these two countries are at a later stage of the demographic transition than the other three, while Brazil has reached this stage more recently. Fertility rates in India are following a similar trend to Brazil, while South Africa's rate is progressing at a much slower pace. Demographic development is inextricably linked with economic growth; for example, as fertility rates drop, female participation in the workforce increases, as does the average age, which then leads to higher productivity and a more profitable domestic market.

The market size was valued at USD 1.5 billion in 2021 and will be 2.2 billion by 2030 with a CAGR of 8.2% during the forecast period. Factors Affecting Infertility TreatmentMarket Growth

Government spending on healthcare facilities

The federal government's increased support will likely accelerate market expansion. Additionally, the development and expansion of the healthcare sector, pushed by both public and private sectors, particularly in developing nations, will provide attractive potential for market expansion. High returns on investments, which are guaranteed by research efforts, would also benefit the market. Additionally, a rise in personal disposable income, an increase in the number of fertility clinics around the world, an increase in investment in the development of cutting-edge medical products and devices, and the growth of emerging Infertility markets will contribute to the market's positive rate of expansion.

Increasing frequency of the infertility

The demand for infertility is growing in male and females that result in an increasing demand for sterile treatment, Delayed parenthood, sexual transmission disease, aging, lifestyles are the factors that impact infertility. Therefore, there is faster growth in this field.

The Restraining Factor of Infertility Treatment:

High cost associated with treatment 

It is anticipated that barriers to market expansion will include high costs associated with research and development capabilities, a lack of adequate infrastructure, and increased complexity and concerns surrounding assisted reproductive technology (ART). In addition, during the forecast period of 2022–2029, the market is anticipated to face challenges from an unfavourable reimbursement scenario, a lack of technology penetration in developing economies, high costs associated with assisted reproductive technology (ART) procedures, and an inadequate infrastructure in low- and middle-income nations. This hampers the infertility market.

Opportunities on Infertility Treatment

Developing economies in APAC and RoW:

Market participants for infertility treatments can anticipate finding significant growth opportunities in developing nations like China, India, Brazil, and Mexico. The Asia market is different from other growing nations, due to greater focus on infrastructure upgrades in the healthcare sector. For a variety of reasons, the medical tourism industry is also booming in developing countries. The quality of the healthcare facilities in Asia is very excellent. The medical procedures are reasonably priced, and many of the physicians and surgeons were educated at renowned universities in the US and Europe. Emerging markets including India, China, Singapore, Thailand, Brazil, and Malaysia offer promising opportunities for the growth of the global market.

Impact of the COVID-19 pandemic on the Infertility Treatment Market:

The market has been negatively impacted by COVID-19. The market growth rate was slowed down as attention was diverted from non-essential healthcare services to meet COVID-19 patient expectations. Guidelines were established to prevent front-line hospital and public employees from contracting the COVID-19 virus. Due to the cancellation of in vitro fertilisation procedures, 90% decrease in the number of people having in vitro fertilisation cycles was seen during this pandemic phase. The infertility market growth rate was hampered as a result of everything. Introduction of Infertility Treatment

Infertility means a woman is not able to conceive after trying for more than a year. Infertility occurs when a woman can become pregnant but tends to experience miscarriages. Infertility treatment largely depends on the underlying cause and objectives. A treatment will be chosen for you based on your age, length of infertility treatment, and personal preferences. Sometimes only one person needs treatment, and other times both spouses must participate. In most circumstances, infertile individuals and couples have a high possibility of getting pregnant. The use of assisted reproductive technology (ART), surgery, or medication can be beneficial.

Baby Diaper Machine Line Market Outlook

The global baby diaper machine line market size was valued at USD 1.5 billion in 2023 and is projected to reach USD 2.6 billion by 2032, growing at a CAGR of 6.2% during the forecast period. This growth can be attributed to a combination of factors including increasing birth rates in developing countries, rising disposable income, and advancements in diaper technology that demand efficient manufacturing processes.

One of the primary growth factors for the baby diaper machine line market is the increasing birth rates in emerging economies such as India, China, and various African nations. These regions are witnessing a rise in population driven by higher fertility rates and decreasing infant mortality rates. As the population grows, the demand for baby diapers also increases, thereby necessitating the need for efficient and high-capacity diaper manufacturing machines. Additionally, the urbanization trend in these regions is contributing to higher disposable incomes, making premium baby care products more accessible to a larger consumer base.

Another significant growth factor is the advancements in diaper technology. Modern-day diapers are designed to offer better absorption, improved fit, and increased comfort. This has led to the development of more sophisticated manufacturing processes, which require state-of-the-art machinery. Innovations such as biodegradable diapers and hypoallergenic materials are also driving the demand for advanced diaper machine lines that can produce these specialized products efficiently. Consequently, manufacturers are increasingly investing in machine upgrades and new installations to keep pace with technological advancements.

The growing awareness about hygiene and infant care is another key driver for market growth. Parents are becoming more conscious about the health and hygiene of their babies, leading to higher spending on baby care products, including diapers. The increasing availability of these products in both online and offline retail channels is making them more accessible to a broader audience. Moreover, government initiatives promoting infant health and hygiene also play a crucial role in boosting the market for baby diaper machines.

Regionally, North America and Europe have traditionally been strong markets for baby diaper machine lines due to the high demand for premium baby care products and advanced manufacturing capabilities. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. This can be attributed to the rapidly growing population, increasing disposable incomes, and the presence of numerous diaper manufacturing plants in countries like China and India. The Middle East & Africa and Latin America are also emerging as potential markets, driven by improving economic conditions and increasing consumer awareness.

Machine Type Analysis

The baby diaper machine line market can be segmented based on machine type into semi-automatic and fully automatic machines. Semi-automatic machines offer a balance between manual intervention and automation, providing flexibility and cost-effectiveness for small to medium-sized manufacturers. These machines are particularly popular in emerging markets where labor costs are relatively low and initial capital investment needs to be minimized. Semi-automatic machines allow manufacturers to scale up production gradually, making them an attractive option for start-ups and small enterprises.

Fully automatic machines, on the other hand, are designed for high-speed, high-volume production. These machines are equipped with advanced features such as real-time monitoring, quality control systems, and automated material handling, which significantly reduce the need for manual intervention. Fully automatic machines are ideal for large-scale manufacturers who need to meet high demand efficiently. The higher initial investment in these machines is often offset by the savings in labor costs and the increased production capacity they offer. As a result, fully automatic machines are gaining traction in developed markets where labor costs are high and production efficiency is paramount.

In terms of market growth, fully automatic machines are expected to witness a higher CAGR compared to semi-automatic machines. This growth is driven by the increasing demand for high-quality diapers and the need for manufacturers to stay competitive by adopting advanced manufacturing technologies. The integration of Industry 4.0 technologies, such as IoT and machine learning, into fully

Life expectancy at birth, total (years) in China was reported at 77.95 years in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Life expectancy at birth, total (years) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

Sex ratio at birth (male births per female births) in China was reported at 1.108 in 2023, according to the World Bank collection of development indicators, compiled from officially recognized sources. China - Sex ratio at birth (male births per female births) - actual values, historical data, forecasts and projections were sourced from the World Bank on July of 2025.

The global infertility testing and treatment market was valued at USD 17.1 billion in 2025 and is projected to reach USD 31.2 billion in 2033, exhibiting a CAGR of 8.4% during the forecast period. The increasing prevalence of infertility worldwide, technological advancements in assisted reproductive technologies (ART), and government initiatives to support infertility treatments are driving the market's growth. Rising awareness about infertility and its potential treatments, coupled with changing societal norms towards childbearing, are further contributing to market expansion. In terms of segmentation, the infertility testing segment accounted for a larger market share in 2025 due to the growing demand for early diagnosis and monitoring of infertility factors. The ART segment, including procedures such as IVF and IUI, is expected to witness significant growth during the forecast period. Key players in the market include Merck, Procter & Gamble, BioMerieux, Abbott, and Babystart, among others. Geographic regions with high birth rates and increasing fertility awareness, such as India and China, are likely to drive the market's growth in the Asia Pacific region. Ongoing research and development efforts to improve the efficacy and accessibility of infertility treatments are also poised to shape the industry's future landscape. Infertility affects millions of couples worldwide, and the demand for effective testing and treatment solutions is on the rise. This report provides a comprehensive overview of the infertility testing and treatment market, including key trends, challenges, growth catalysts, and leading players.